Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
about
pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.Supramolecular cyclodextrin-based drug nanocarriers.Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.Construction and Characterization of a Chitosan-Immobilized-Enzyme and β-Cyclodextrin-Included-Ferrocene-Based Electrochemical Biosensor for H₂O₂ Detection.Conjugates of methylated cyclodextrin derivatives and hydroxyethyl starch (HES): Synthesis, cytotoxicity and inclusion of anaesthetic actives.Functionalized and graft copolymers of chitosan and its pharmaceutical applications.Poly(ethylene glycol) and Cyclodextrin-Grafted Chitosan: From Methodologies to Preparation and Potential Biotechnological Applications.An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery.Chitosan nanoparticles functionalized with β-cyclodextrin: a promising carrier for botanical pesticides.Synthesis of β-cyclodextrin hydrogel nanoparticles for improving the solubility of dexibuprofen: characterization and toxicity evaluation.Biomacromolecules as carriers in drug delivery and tissue engineering.Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticlesFunctionalization of chitosan via single electron transfer living radical polymerization in an ionic liquid and its antimicrobial activity
P2860
Q36367986-F27183DF-A78A-4AB8-A6E4-D13008D1753FQ38225019-AEA11A57-AB25-4BA8-86D1-7453B9F718FFQ38354545-BAC32212-0A1F-4623-B449-4B8097B7F738Q38706868-9607BBD4-2AFE-4688-B159-E626849C2B99Q40741687-98ADB46D-BC9F-404E-9047-F5D7BB294992Q41574810-9446A3B5-5061-43D7-AAF8-670675571BDCQ42154235-7BD282BC-824E-48CE-A442-278AC2E29E5BQ44867110-802235FB-388A-43AD-9307-A59D67D4CB5FQ47150939-A14C503B-6704-4E3C-B624-C885DB3BCDD9Q47961163-E6FE17D9-DCC1-432A-B737-FCCBE98B4C4CQ49166326-DFE0F3E4-EC21-459F-85C2-167DF6A61A26Q53579113-10C7D466-1F4D-4D83-8AA9-C9FF96075E9DQ55114332-73420D26-F51F-43B9-ABDE-B948D3629F90Q57070396-A36F9150-F70A-4274-8CCA-905B05FFE15CQ57342367-4DB1CBFC-6E9D-4AA2-AD1D-679CA06A626E
P2860
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
@ast
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
@en
type
label
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
@ast
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
@en
prefLabel
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
@ast
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
@en
P2093
P1476
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release
@en
P2093
P304
P356
10.1016/J.IJPHARM.2013.02.024
P407
P50
P577
2013-02-16T00:00:00Z